CYBER-INTELLIGENCE-HOUSE
19.11.2021 09:02:09 CET | Business Wire | Press release
Hoxhunt, a premium enterprise cybersecurity awareness training platform, and Cyber Intelligence House, a leading provider of cyber intelligence, today announced a first-of-its-kind partnership designed to equip organizations with unprecedented protection from email attacks leveraging advanced insight across their dark-web-to employee-inbox lifecycle.
Hoxhunt’s CEO, Mika Aalto stated:
“This partnership with Cyber Intelligence House will open a whole new category of proactive cybersecurity awareness. Their industry-leading Cyber Exposure Platform adds a superior breadth and depth of intelligence from the Darkweb, Deep web and cyberspace forums and marketplaces to our dynamic awareness platform, typically 16 times more data than other solutions. By connecting threat intelligence with awareness, we can transform insight into foresight. Just imagine knowing an attack is likely coming and being able to train your employees with simulations of the actual phishing templates hackers purchased for their attack”.
Cyber Intelligence House’s CEO, Mikko Niemela adds:
“We are very excited to be partnering with Hoxhunt. Their best-in-class Cyber Awareness and Training platform allows organisations to adapt and defend against the ever rising volume of cyber threats that our platform identifies”.
About Hoxhunt:
Hoxhunt is a People-First Cybersecurity Platform that protects organizations and their employees from the risk of cyber attacks. Hoxhunt’s cognitive automation maps individually adaptive training curriculum to each employee’s skill level for optimal engagement. Hoxhunt empowers individuals with the tools and confidence to recognize and respond to attacks dynamically over time.
Hoxhunt enables security teams with real-time visibility into threats so they can react fast and limit their spread. The entire platform is autonomous, freeing up considerable time for security teams to focus on what matters.
To learn more about Hoxhunt, please visit https://www.hoxhunt.com or email info@hoxhunt.com .
About Cyber Intelligence House:
Cyber Intelligence House is a leading cyber intelligence company specialised in helping cyber security professionals and law enforcement to assess and monitor cyber exposure from the dark web, deep web, data breaches and online-assets. It is the trusted provider to government and law enforcement agencies globally, including Interpol and UNODC.
Cyber Intelligence House’s Cyber Exposure Platform (CEP) provides the world’s most comprehensive Cyber Threat database with over 10 years of data. 24/7 and collection and storing of new data at a rate of ~600 pages per second. CEP delivers unrivalled search and alerting performance with Deep scanning of over 250 metadata factors and machine learning enabled categorization of threats to provide deep insights into potential cyber threats.
To learn more about Cyber Intelligence House, please visit https://www.cyberintelligencehouse.com or email info@cyberintelligencehouse.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20211119005005/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements15.6.2026 12:00:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated June 10, 2026 (the "Notification Letter"), from Hearing Advisor of The Nasdaq Stock Market LLC., indicating that the Company has regained compliance with Listing Rule 5250(c)(1) and that the Company is therefore in compliance with the Nasdaq Global Market's listing requirements. As noted in the Hearing Panel's May 20, 2026 compliance determination, the Company remains under a Mandatory Panel Monitor pursuant to Listing Rule 5815(d)(4)(B) until May 20, 2027. The Company filed its annual report on Form 20-F for the year ended December 31, 2025 on June 5, 2026. The Notification Letter also stated that the hearing before the Hearings Panel, applied for by the Company, had accordingly been canceled. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission
KRM22 partners with Sigma AI to enhance market surveillance and risk intelligence capabilities15.6.2026 12:00:00 CEST | Press release
KRM22, the technology and software investment company focused on risk management solutions for capital markets, today announced a strategic partnership with Sigma AI, a leading provider of AI-driven financial insights, to integrate advanced news sentiment analytics into its risk management application suite. The integration marks a significant enhancement to KRM22’s capabilities, enabling clients to incorporate real-time market sentiment insights derived from global news sources directly into their risk frameworks. By leveraging Sigma AI’s proprietary natural language processing and machine learning models, KRM22 will help firms better identify emerging risks, anticipate market-moving events, and make more informed trading and compliance decisions. Advancing risk management through AI-driven sentiment analysis As part of the first phase of the collaboration, KRM22 will embed Sigma AI’s news sentiment engine within its application suite. This will provide users with actionable intellige
HUI (HUI:VSE) Merges Traditional and Crypto Finance: Commences Continuous Trading in Vienna With Leading Market Maker and Announces Impending Token Listing on Major Global Exchange15.6.2026 11:15:00 CEST | Press release
The first SaaS SuperApp for startups and VCs capitalizes on a $25M round a from Nimbus Capital and a +15% stock surge, unveiling a v3/v4 roadmap that bridges public equity with digital asset liquidity. HUI S.p.A., the pioneering vertical SuperApp and SaaS company dedicated to the global Venture Capital and startup ecosystem listed on the Vienna Stock Exchange, today released its global product strategy, marking an unprecedented convergence between traditional regulated markets and decentralized finance. Driven by a +15% stock surge and the consolidation of its $25 million round a equity commitment fully subscribed by global institutional fund Nimbus Capital, the company announced its upcoming transition to continuous trading on the Vienna market in partnership with a leading European market maker, alongside the activation of the initial PUT options tied to the round. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2026061293689
Syngenta Signs MoU to Be Strategic Partner in India’s First Open-Data Agricultural Ecosystem Annam.AI15.6.2026 09:35:00 CEST | Press release
Agricultural innovation leader to contribute with agronomic expertise in building accurate crop health, pest forecasting and heat stress models India’s agriculture sector is a global powerhouse, uniquely characterized by its massive scale, vast arable land, diverse agro-climatic zones and rich biodiversity. These strengths have propelled the country to become one of the world’s leading producers of crops such as rice and wheat. However, farmers in the country face significant challenges – from erratic monsoons, severe droughts and unseasonal rains compounded by El Nino, to pests and diseases that destroy an estimated 30 percent of crops annually. More than 80 percent of India’s estimated 150 million farming households are composed of smallholder farmers who operate on less than two hectares of land. This limits economies of scale, sets obstacles to the wider adoption of advanced technologies and could widen a systemic gap between large commercial agricultural operations and the bulk of
Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry15.6.2026 09:00:00 CEST | Press release
The combination unites Pelago Bioscience’s industry-leading and proprietary cellular target engagement capabilities with RG Discovery’s deep medicinal chemistry and custom synthesis expertise - enabling customers to advance drug discovery programs across the full design-make-test-analyze-(DMTA) cycle with a single specialist partner. Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement assays, is pleased to announce the acquisition of RG Discovery, and thereby adding deep expertise in medicinal chemistry, custom synthesis, and integrated drug discovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615340933/en/ Michael Dabrowski, Chief Executive Officer of Pelago Bioscience By combining Pelago Bioscience's biology-focused capabilities with RG Discovery's chemistry expertise, the enlarged platform will enable drug discover
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom